Wednesday, 24 May 2017

Generics News

  • Bioscience firms queue up for Japan market

    Generics |  Analysis | By Narayan Kulkarni | 0 Comment

    Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into an aging society. A survey by the country's Ministry of Internal Affai...Read more

  • FDA clears 152 antiretroviral drugs for HIV/AIDS program

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The US Food and Drug Administration (FDA) has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Rel...Read more

  • Wockhardt gets FDA nod for generic treatment of enlarged prostate

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Mumbai: Pharmaceutical and biotechnology major Wockhardt has received final approval from the US Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuz...Read more

  • RPG issued warning letter by US FDA

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: In what has come as another shocker for the Indian Pharmaceutical industry, the US FDA slammed RPG Life Sciences with a warning letter. The US FDA is said to have found two manu...Read more

  • Dr. Reddy's rides on biosimilar product line

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    India-headquartered Dr Reddy's Laboratories is making a strong name in biosimilars business in India and in the world. In 2011, the company focused on introducing new biosimilars, reachin...Read more

  • Sun Pharma to acquire Ranbaxy

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: India based generics firm Sun Pharmaceutical Industries has announced to acquire Ranbaxy Laboratories through an all-stock transaction. Under the deal, Ranbaxy shareholders will ...Read more

  • Dr. Reddy's launches generic of Boniva

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market, following the approval by the US Fo...Read more

  • Lupin acquires Mexican firm Laboratorios Grin

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Foraying into South American pharmaceutical market, India based Lupin Pharmaceutical has acquired Mexico firm Laboratorios Grin. Mexico is one of the fastest growing pharmaceutic...Read more

  • Asia pharma industry to touch $386 bn:Report

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition and ...Read more

  • Pharmaniaga report 51% jump in net profit

    Generics |  Company results | By BioSpectrum Bureau | 0 Comment

    Singapore: Pharmaniaga Berhad, the largest integrated local healthcare company in Malaysia, reported a jump of 51 percent in its net profit to $14.3 million (RM44.4 million) in the first si...Read more

  • Glenmark generics business grows by 34%

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Glenmark Pharmaceuticals has consolidated $254.45 million for the third quarter ending December 31, 2012, marking an increase of 33.96 percent. Revenue from the generics business...Read more

  • Generics challenge pharma drug pricing regime

    Generics |  Opinion | By Nandita Singh | 0 Comment

    Healthcare systems, globally, are grappling with different facets of the same problem: How to provide affordable healthcare to 100 percent of its citizens? Almost all countries look up to ...Read more

  • India: PSUs need to be revived to boost generics

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Raising concerns related to the fate of people who cannot afford expensive branded medicines, India's parliamentary committee has made suggestions that would help boost generic d...Read more

  • Debate over compulsory licensing of Bayer's Nexavar

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Thecase of Indian pharma company's request for a compulsory license to make a generic version of Bayer's patented drug to treat liver and kidney cancer was settled on March 13, 2012. In a f...Read more

  • British drug major GSK awaits Chinese probe details

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Even six days after Chinese police detailed some senior executives working at the Chinese office of the biggest British drugmaker, GlaxoSmithKline, the company has no information...Read more

  • Glenmark-MSD patent suit put on hold by Indian HC

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In what looked like a patent suit that could stir further controversy about patenting in the life sciences industry, US drug major Merck Sharp and Dohme (MSD) filed a patent agai...Read more

  • Aged society fuels growth of generics

    Generics |  Analysis | By Narayan Kulkarni | 0 Comment

    A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great concern for the Japanese government. To ease spending on healthcare, th...Read more

  • GSK China VP confesses in bribery scandal

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A day after Chinese police made the names of those involved in one of the country's biggest scandal involving a major pharmaceutical company public, GlaxoSmithKline China's vice ...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls